Key result
Adjunct intra-arterial thrombolysis after EVT increases excellent 90-day functional outcomes by ~16%.
Why the study?
Does intra-arterial thrombolysis following successful endovascular thrombectomy improve excellent functional outcomes at 90 days in patients with acute ischemic stroke due to large vessel occlusion?
Meta-Analysis (n=1,395)
Does intra-arterial thrombolysis following successful endovascular thrombectomy improve excellent functional outcomes at 90 days in patients with acute ischemic stroke due to large vessel occlusion?
Answers are grounded in this paper and cite their sources.
Adjunct intra-arterial thrombolysis following successful endovascular thrombectomy in acute ischemic stroke patients with large vessel occlusion improves the likelihood of achieving an excellent functional outcome at 90 days without significantly increasing symptomatic intracranial hemorrhage or mortality.
INTRODUCTION: The impact of intra-arterial thrombolysis (IAT) following successful endovascular thrombectomy (EVT) in patients with acute ischemic stroke (AIS) due to large vessel occlusion (LVO) remains uncertain. This study aims to assess the efficacy and safety of IAT as an adjunct to EVT in patients with AIS-LVO. PATIENTS AND METHODS: We searched PubMed, Embase, and Cochrane databases to identify randomized controlled trials (RCTs) that compared EVT + IAT with EVT-only for AIS-LVO. The primary outcome was an excellent functional outcome, defined as a modified Rankin Scale (mRS) score of 0-1 at 90 days. Secondary outcomes included functional independence (mRS 0-2), symptomatic intracranial hemorrhage (sICH), and mortality. The pooled data were analyzed using random-effects models. DISCUSSION AND CONCLUSION: A total of four RCTs, involving 1395 patients, were included in the analysis. The results showed that patients who received EVT + IAT had a significantly higher likelihood of achieving an excellent functional outcome at 90 days compared to those who received EVT-only (risk ratio [RR], 1.16; 95% confidence interval [CI], 1.03-1.31). No statistically significant differences were observed between the EVT + IAT and EVT-only groups in terms of 90-day functional independence (RR, 1.03; 95% CI, 0.94-1.13), sICH (RR, 1.30; 95% CI, 0.80-2.13), or 90-day mortality (RR, 0.94; 95% CI, 0.76-1.17). CONCLUSIONS: Among patients with AIS-LVO who have undergone successful EVT, the use of adjunct IAT, compared to no additional treatment, was associated with a greater likelihood of achieving an excellent functional outcome at 90 days. SYSTEMATIC REVIEW REGISTRATION: CRD42024602099.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) conducted a meta-analysis in Acute ischemic stroke due to large vessel occlusion (n=1,395). Intra-arterial thrombolysis (IAT) as an adjunct to endovascular thrombectomy (EVT) vs. Endovascular thrombectomy (EVT) only was evaluated on Excellent functional outcome (modified Rankin Scale score of 0-1 at 90 days) (RR 1.16, 95% CI 1.03-1.31). Adjunct intra-arterial thrombolysis following successful endovascular thrombectomy significantly increased the likelihood of achieving an excellent functional outcome at 90 days (RR 1.16; 95% CI 1.03-1.31).
Synapse has enriched 10 related papers. Consider them for comparative context: